Mazen Soliman Abdel Fakeeh Dr. Soliman Abdel Kader Fakeeh Hospital Company's (TADAWUL:4017) CEO is the most bullish insider, and their stock value gained 4.1%last week
Key Insights
- Dr. Soliman Abdel Kader Fakeeh Hospital's significant insider ownership suggests inherent interests in company's expansion
- The top 2 shareholders own 62% of the company
- Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock
Every investor in Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017) should be aware of the most powerful shareholder groups. We can see that individual insiders own the lion's share in the company with 78% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
As a result, insiders scored the highest last week as the company hit ر.س9.2b market cap following a 4.1% gain in the stock.
In the chart below, we zoom in on the different ownership groups of Dr. Soliman Abdel Kader Fakeeh Hospital.
See our latest analysis for Dr. Soliman Abdel Kader Fakeeh Hospital
What Does The Institutional Ownership Tell Us About Dr. Soliman Abdel Kader Fakeeh Hospital?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
Institutions have a very small stake in Dr. Soliman Abdel Kader Fakeeh Hospital. That indicates that the company is on the radar of some funds, but it isn't particularly popular with professional investors at the moment. If the company is growing earnings, that may indicate that it is just beginning to catch the attention of these deep-pocketed investors. It is not uncommon to see a big share price rise if multiple institutional investors are trying to buy into a stock at the same time. So check out the historic earnings trajectory, below, but keep in mind it's the future that counts most.
Dr. Soliman Abdel Kader Fakeeh Hospital is not owned by hedge funds. With a 31% stake, CEO Mazen Soliman Abdel Fakeeh is the largest shareholder. With 31% and 16% of the shares outstanding respectively, Ammar Soliman Abdel Fakeeh and Manal Soliman Abdel Fakeeh are the second and third largest shareholders. Interestingly, the third-largest shareholder, Manal Soliman Abdel Fakeeh is also a Vice Chairman, again, indicating strong insider ownership amongst the company's top shareholders.
After doing some more digging, we found that the top 2 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.
Insider Ownership Of Dr. Soliman Abdel Kader Fakeeh Hospital
The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
Our most recent data indicates that insiders own the majority of Dr. Soliman Abdel Kader Fakeeh Hospital Company. This means they can collectively make decisions for the company. Insiders own ر.س7.2b worth of shares in the ر.س9.2b company. That's extraordinary! Most would be pleased to see the board is investing alongside them. You may wish to discover if they have been buying or selling.
General Public Ownership
With a 21% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Dr. Soliman Abdel Kader Fakeeh Hospital. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
Next Steps:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too.
Many find it useful to take an in depth look at how a company has performed in the past. You can access this detailed graph of past earnings, revenue and cash flow.
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Valuation is complex, but we're here to simplify it.
Discover if Dr. Soliman Abdel Kader Fakeeh Hospital might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.